Skip to content

Effect of human composition on prognosis of patients with hepatocellular carcinoma after Transhepatic Arterial Chem Otherapy And Embolization(TACE)

Effect of human composition on prognosis of patients with hepatocellular carcinoma after Transhepatic Arterial Chem Otherapy And Embolization(TACE)

Status
Recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058127
Enrollment
Unknown
Registered
2022-03-30
Start date
2022-04-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma (HCC)

Interventions

TACE gruop:None

Sponsors

Affiliated Hospital of Southwest Medical University,
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Phase I: 1.Age =18, clear mind, fluent speech, answer to the question; 2.Hepatocellular carcinoma was diagnosed according to the diagnostic criteria for Primary Liver Cancer Diagnosis and Treatment (2021 edition); 3.Complete clinical data. Phase 2: 1.Hepatocellular carcinoma was diagnosed according to the diagnostic criteria for Primary Liver Cancer Diagnosis and Treatment (2021 edition); 2.Patients receiving initial diagnosis of HCC and TACE.

Exclusion criteria

Exclusion criteria: Phase I: 1. Complicated with serious basic diseases, Such as: serious heart disease, malignant hypertension, poorly controlled diabetes, etc; 2. Those who combine related basic diseases and transfer them to relevant departments for further treatment; 2. Patients with poor ascites control (affecting BMI value). Phase II: 1. Previous medical history of other tumors; 2. Have received biological targeted therapy; 3. Lack of CT imaging data for judging Src and obesity before TACE treatment; 4. Follow up patients not treated according to the specification.

Design outcomes

Primary

MeasureTime frame
Skeletal muscle area of the third lumbar plane;body mass index;

Countries

China

Contacts

Public ContactWang Min

Affiliated Hospital of Southwest Medical University

12110875@qq.com+86 18716135801

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026